GovChime
Notice ID: 7833667a0c414bb6bc2a5d73c77461f2Special Notice

Classical Swine Fever (CSF) Virus Vaccine

Archived on January 2, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−06:00
Posted
December 2, 2021
Notice type
Special Notice
NAICS
325414: Biological Product (except Diagnostic) Manufacturing
Agency
Department of Agriculture

Notice details

Place of performance
Ottignies-Louvain-la-Neuve
Last updated
Sep 25, 2026

Identifiers

Solicitation number
12639522R0010
Notice ID
7833667a0c414bb6bc2a5d73c77461f2

Description

Pursuant to FAR 13.5 and FAR 6.302-1, USDA, Animal and Plant Health Inspection Service (APHIS), intends to award a sole source supply contract in that only one responsible source and no other providers will satisfy agency requirements (see attached justification). The contract will be for a one-time purchase of one million doses of Classical Swine Fever Virus (CSF) Vaccine that is capable of differentiating infected from vaccinated animals (DIVA). The contract will also include contractor storage of vaccine. This will be a Firm-Fixed Price (FFP) contract under FAR PART 12 Acquisition of Commercial Items with Zoetis US, LLC, 10 Sylvan Way, Parsippany, NJ 07054. DUNS 078579659. This is not a request for competitive proposals. The Government seeks to purchase one million doses of the CSF vaccine per the attached draft statement of work. The requirement is essential to meeting the government's needs. Any interested sources including small businesses capable of providing the product are encouraged to provide detailed capability information. A determination by the Government not to compete this requirement will be based on responses and 9 CFR 104.2 since only permitted products may be purchased. No requests for capability briefings will be honored as a result of this notice. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. The Government will not award a contract based on the information received, nor reimburse participants for information they provide. Information provided is strictly voluntary. Please email Larry Nelson at Larry.D.Nelson@usda.gov. Closing date of this notice is December 16, 2021. The North American Industry Classification Code (NAICS) is 325414 with a small business size standard of less than 1,250 employees.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:12639522R0010
  1. Special NoticeCurrentDec 2, 2021

    Classical Swine Fever (CSF) Virus Vaccine

    Notice 7833667a0c414bb6bc2a5d73c77461f2 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0035 for an unrestrictive procurement for the Influenza Virus Vaccine for the Department of Veterans Affairs (VA) to include State Veteran Homes option 2 (SVH2 s), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC) for the 2027-2028 Influenza Season. Evaluation and award will be made by solicitation line item for VA, BOP, IHS, and FHCC requirements. Offerors are not required to submit an offer for every line item; however, the offeror must offer the full quantity for each line item offered. Additionally, all offered line items for a single presentation must be offered at the same unit price. Please note that the final offered price must include the Cost Recovery Fee (CRF) and Federal Excise Tax (FET). Orders will be placed by and delivered to VA, SVH2, BOP, and IHS facilities throughout the United States, the Philippines and Puerto Rico. The contractor(s) will be required to deliver the vaccine Free On Board (FOB) Destination to Government facilities within the U.S., Philippines, and Puerto Rico. The first shipment of product ordered must be at least 50% of each individual facility s ordered quantity and must be delivered between August 15, 2027, and September 15, 2027. The second shipment must be for the remaining individual facility s entire ordered quantity and must be delivered between September 16, 2027, and October 15, 2027. FHCC shall receive 100% of the awarded quantities between August 15, 2027 and September 15, 2027. Solicitation number 36E79726R0035 is estimated to be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 8, 2026, with a closing date of September 24, 2026. ESTIMATED ANNUAL REQUIREMENTS BY AGENCY PRESENTATION DESCRIPTION PACKAGE TYPE VA EST ANNUAL USAGE BOP EST ANNUAL USAGE IHS EST ANNUAL USAGE FHCC EST ANNUAL USAGE TOTAL ESTIMATED ANNUAL USAGE 1 Influenza Virus Vaccine: Pre-filled single dose syringes with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free: for persons 36 months. SYRINGE (Box of 10) 120,000 6,129 27,200 550 153,879 2 I Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free; must be specifically designed for persons 65 years and older as approved by the FDA. SYRINGE (Box of 10) 110,000 280 11,000 400 121,680 3 Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season. Must be split virus vaccine (subvirion or purified surface antigen) that has been FDA approved and labeled with indications for administration to children 6 months - 35 months of age (pediatric), latex and preservative free. SYRINGE (Box of 10) 0 0 1,000 0 1,000 The final vaccine presentation for each line item (Trivalent or Quadrivalent) shall be based on recommendations issued by WHO. If WHO recommends both Trivalent and Quadrivalent influenza strain presentations, and both are commercially available from the offeror or contract awardee, the Trivalent presentation shall be required.
76%
Pre-Solicitation09/08/2026
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Proposals are being requested and a separate written solicitation will not be issued. Solicitation number 12639527R0001 is issued as a Request for Proposal (RFP) for the purchase and storage of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), conversion of Government owed VAC into usable vaccine, and the direct purchase of finished vaccine. This acquisition is not set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325414. The small business size standard is 1,250. This acquisition is an unrestricted requirement. All responsible sources may submit a proposal which will be considered by the agency.
66%
Combined Synopsis11/10/2026
Influenza Vaccine Solicitation: SPE2DP26R0003
64%
Solicitation12/03/2026
The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. The formula for the 2027-2028 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate. All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 12, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (rosbert.jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September 28, 2026, closing on Ocrtober 14, 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
63%
Solicitation10/14/2026
Egg-Free Influenza Vaccine Solicitation: SPE2DP26R0004
62%
Solicitation12/03/2026

Additional Details

Solicitation Number

12639522R0010

Archive Date

Jan 2, 2022

Place of Performance Country

BEL

Office Address

US